HLL Lifecare Declares Record Dividend Amid Strong Growth in FY 2024-25

HLL Lifecare Limited has made headlines with its impressive financial performance, declaring a record dividend of Rs 69.53 crore to the Health Ministry for the fiscal year 2024-25. This payment signifies not only the company's robust financial health but also a promising 20% increase in revenue compared to the previous fiscal year.

Remarkable Achievements

• Record Dividend Paid: HLL Lifecare set a new benchmark with the dividend amount of Rs 69.53 crore.
• Revenue Growth: The company has demonstrated an exceptional 20% growth in revenue.
• Social Impact: The Amrit pharmacies, a significant initiative by HLL, have positively impacted over 6.7 crore people, demonstrating the company's commitment to public health.
• Cost Savings: HLL Lifecare's efforts have led to substantial savings of Rs 8,000 crore in healthcare expenses for citizens, showcasing the effectiveness of its services.

Recognition from Government

Union Health Minister J.P. Nadda has openly recognized HLL Lifecare’s contributions to the healthcare sector, applauding the positive influence of their Amrit pharmacies. These pharmacies are crucial in promoting affordable healthcare and ensuring that essential medications are accessible to a broad population, significantly impacting national health outcomes.

Conclusion

HLL Lifecare Limited continues to lead in the healthcare sector with its recent dividend declaration and robust revenue growth. By improving accessibility and affordability in healthcare, they not only pave the way for financial stability but also emphasize their ongoing commitment to enhancing the quality of life for millions of Indians. With such achievements, HLL Lifecare sets a positive example for businesses in the healthcare industry and beyond.